GGrantIndex
← Leaderboards

Timothy A Graubert

Washington University

$17,171,795
Attributed
$20,507,152
Total exposure
14
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$21,006,152 · 15

By mechanism

K12$6,670,714 · 1
P01$4,498,838 · 2
RC2$2,456,842 · 1
R01$2,083,692 · 1
P50$2,069,177 · 2
P30$1,506,126 · 2

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Base

Research focus

BaseSamplingMemberInstitutionResearch PersonnelTrainingFundingGenesMalignant NeoplasmsLeukemiaAllelesProgramsMutatePathway InteractionsGrantMonitorGeneticHematopoieticRecurrenceDysmyelopoietic SyndromesMutationIn VitroCellsIn Vivo

Grant awards (53)

Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology$804,156
K12 · FY2025 · CA · contact PI
Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology$617,615
K12 · FY2024 · CA · contact PI
Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology$810,000
K12 · FY2023 · CA · contact PI
Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology$749,749
K12 · FY2022 · CA · contact PI
Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology$870,551
K12 · FY2021 · CA · contact PI
Career Enhancement Program$20,550
P50 · FY2021 · CA · contact PI
Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology$959,799
K12 · FY2020 · CA · contact PI
Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology$959,795
K12 · FY2019 · CA · contact PI
Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology$899,049
K12 · FY2018 · CA · contact PI
Genomics of Familial MDS/AML$178,530
P01 · FY2018 · CA · contact PI
Career Enhancement Program$102,671
P50 · FY2018 · CA · contact PI
RNA Splicing Modulators for MDS/AML$427,150
P50 · FY2017 · CA · contact PI
Genomics of Familial MDS/AML$339,464
P01 · FY2017 · CA · contact PI
Career Enhancement Program$98,680
P50 · FY2017 · CA · contact PI
RNA Splicing Modulators for MDS/AML$401,522
P50 · FY2016 · CA · contact PI
Genomics of Familial MDS/AML$338,993
P01 · FY2016 · CA · contact PI
RNA Splicing Modulators for MDS/AML$344,994
P50 · FY2015 · CA · contact PI
Genomics of Familial MDS/AML$336,142
P01 · FY2015 · CA · contact PI
RNA Splicing Modulators for MDS/AML$333,788
P50 · FY2014 · CA · contact PI
Genomics of Familial MDS/AML$323,370
P01 · FY2014 · CA · contact PI
High Speed Cell Sorter Core$139,245
P30 · FY2014 · CA · contact PI
RNA Splicing Modulators for MDS/AML$339,822
P50 · FY2013 · CA · contact PI
Genomics of Familial MDS/AML$330,676
P01 · FY2013 · CA · contact PI
High Speed Cell Sorter Core$137,068
P30 · FY2013 · CA · contact PI
Genomics of Treatment -Related Acute Myelogenous Leukemia: Susceptibility Factors$514,236
P01 · FY2012 · CA · contact PI
High Speed Cell Sorter Core$142,655
P30 · FY2012 · CA · contact PI
High Speed Cell Sorter Core$2,777
P30 · FY2012 · CA · contact PI
Genomics of Treatment -Related Acute Myelogenous Leukemia: Susceptibility Factors$808,063
P01 · FY2011 · CA · contact PI
High Speed Cell Sorter Core$89,173
P30 · FY2011 · CA · contact PI
WHOLE GENOME SEQUENCING OF MYELODYSPLASTIC SYNDROMES$1,232,000
RC2 · FY2010 · HL · contact PI
Genomics of Treatment -Related Acute Myelogenous Leukemia: Susceptibility Factors$451,176
P01 · FY2010 · CA · contact PI
High Speed Cell Sorter Core$93,750
P30 · FY2010 · CA · contact PI
WHOLE GENOME SEQUENCING OF MYELODYSPLASTIC SYNDROMES$1,224,842
RC2 · FY2009 · HL · contact PI
Genomics of Treatment -Related Acute Myelogenous Leukemia: Susceptibility Factors$443,653
P01 · FY2009 · CA · contact PI
Genomics of myelodysplastic syndromes$497,597
R01 · FY2008 · HL · contact PI
Genomics of Treatment -Related Acute Myelogenous Leukemia: Susceptibility Factors$434,535
P01 · FY2008 · CA · contact PI
Core--High Speed Cell Sorter Facility$279,723
P30 · FY2008 · CA · contact PI
Genomics of myelodysplastic syndromes$19,927
R01 · FY2008 · HL · contact PI
Genomics of myelodysplastic syndromes$507,752
R01 · FY2007 · HL · contact PI
Core--High Speed Cell Sorter Facility$293,110
P30 · FY2007 · CA · contact PI
Genomics of myelodysplastic syndromes$522,916
R01 · FY2006 · HL · contact PI
Core--High Speed Cell Sorter Facility$112,795
P30 · FY2006 · CA · contact PI
Genomics of myelodysplastic syndromes$535,500
R01 · FY2005 · HL
Acquistion of an inFlux GMP cell sorter.$499,000
S10 · FY2005 · RR
ACQUISTION OF AN INFLUX GMP CELL SORTER: ADULT HUMAN STEM CELLS$294,410
S10 · FY2005 · RR
ACQUISTION OF AN INFLUX GMP CELL SORTER: IMMUNOLOGY$189,620
S10 · FY2005 · RR
Core--High Speed Cell Sorter Facility$109,510
P30 · FY2005 · CA
ACQUISTION OF AN INFLUX GMP CELL SORTER: INFECTIOUS DISEASE$14,970
S10 · FY2005 · RR
Core--High Speed Cell Sorter Facility$106,320
P30 · FY2004 · CA
GENETIC TARGETING OF HEMATOPOIETIC STEM CELLS$106,647
K08 · FY2002 · HL
ACQUISTION OF A CYTOMATION MOFLO CELL SORTER$402,822
S10 · FY2001 · RR
GENETIC TARGETING OF HEMATOPOIETIC STEM CELLS$106,647
K08 · FY2001 · HL
GENETIC TARGETING OF HEMATOPOIETIC STEM CELLS$106,647
K08 · FY2000 · HL